Abstract: Provided are: a method for preparing a decellularized tissue product in which decellularized tissue can be filled with liquid while changes in the structure of support tissue constituting the decellularized tissue are inhibited; and a graft provided with a decellularized tissue product. The method for preparing a decellularized tissue product includes a reduced-pressure step for bringing an animal-derived decellularized tissue material and a liquid into contact under reduced-pressure conditions, and/or a pressurized step for bringing same into contact under pressurized conditions. The graft is provided with a decellularized tissue product prepared by the method of preparation.

Abstract: Provided are: a method for preparing a decellularized tissue product in which decellularized tissue can be filled with liquid while changes in the structure of support tissue constituting the decellularized tissue are inhibited; and a graft provided with a decellularized tissue product. The method for preparing a decellularized tissue product includes a reduced-pressure step for bringing an animal-derived decellularized tissue material and a liquid into contact under reduced-pressure conditions, and/or a pressurized step for bringing same into contact under pressurized conditions. The graft is provided with a decellularized tissue product prepared by the method of preparation.

Abstract: An optical fiber array is formed by including m number of optical fibers (where, m is a natural number other than 0), an optical fiber aligning member on a surface of which, at least m number of grooves are formed in parallel, and a cover. An end portion of the optical fiber is disposed in the groove of the optical fiber aligning member, and is held by the optical fiber aligning member and the cover. Furthermore, when being held by the optical fiber aligning member and the cover, by setting a line segment which has connected a point on an outer periphery in contact with the cover, of the optical fiber to be a straight line, the optical fiber is supported at three points by the groove and the cover.

Abstract: An optical fiber array is formed by including m number of optical fibers (where, m is a natural number other than 0), an optical fiber aligning member on a surface of which, at least m number of grooves are formed in parallel, and a cover. An end portion of the optical fiber is disposed in the groove of the optical fiber aligning member, and is held by the optical fiber aligning member and the cover. Furthermore, when being held by the optical fiber aligning member and the cover, by setting a line segment which has connected a point on an outer periphery in contact with the cover, of the optical fiber to be a straight line, the optical fiber is supported at three points by the groove and the cover.

Abstract: An aromatic polycarbonate resin composition comprising: 100 parts by weight of a resin component consisting of (1) 50 to 100 wt % of an aromatic polycarbonate resin (component A) and (2) 0 to 50 wt % of at least one thermoplastic resin (component B) selected from the group consisting of a thermoplastic polyester resin (component B-1) and a styrene unit component-containing resin having a rubber component content of less than 40 wt % (component B-2); and (3) 1 to 100 parts by weight of wollastonite particles having such particle shape characteristics that the particles have a number average fiber length measured by a method specified in this text of 10 &mgr;m or less and a number average fiber diameter measured by a method specified in this text of 4 &mgr;m or less and include particles having a fiber length of 5 to 25 &mgr;m in a number proportion of less than 50% of the total and moldings thereof.

Abstract: An aromatic polycarbonate resin composition comprising:

Abstract: An animal cell capable of producing an antibody specific to a human growth hormone having a molecular weight of 20,000 (20 k hGH) was prepared from an animal immunized with 20 k hGH. The animal cell was fused with a myeloma cell to produce a monoclonal antibody which specifically reacted to 20 k hGH, but substantially not to 22 k hGH. The monoclonal antibody was useful for immunoassay of 20 k hGH.

Abstract: An animal cell capable of producing an antibody specific to a human growth hormone having a molecular weight of 20,000 (20 k hGH) was prepared from an animal immunized with 20 k hGH. The animal cell was fused with a myeloma cell to produce a monoclonal antibody which specifically reacted to 20 k hGH, but substantially not to 22 k hGH. The monoclonal antibody was useful for immunoassay of 20 k hGH.